跳至主要内容
临床试验/ITMCTR2100005429
ITMCTR2100005429招募中1 期

Clinical Study of Fangji Huangqi Decoction in Treating Chronic Heart Failure

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • (1) Meet the diagnostic criteria of chronic heart failure in western medicine;
  • (2) Comply with the syndrome differentiation standard of chronic heart failure with Qi deficiency and blood stasis combined with water in-drinking stop syndrome;
  • (3) LVEF<50% and NT-proBNP>450ng/l;
  • (4) NYHA classification of heart function is ?~?;
  • (5) There is no restriction on gender;
  • (6) 18 years old = age = 85 years old;
  • (7) Sign the informed consent form.

排除标准

  • (1) Patients with acute coronary syndrome, acute myocardial infarction within 6 months, patients with revascularization within 6 months, or patients with planned revascularization within 1 week, cardiogenic shock, fatal arrhythmia, Cardiomyopathy, rheumatic heart valve disease, myocarditis, constrictive pericarditis, pulmonary embolism, etc.;
  • (2) Patients with severe liver and kidney dysfunction [ALT and or AST> 3 times the upper limit of the normal reference value; GFR <30ml/(min·1.73m2)];
  • (3) Combined with serious primary diseases such as endocrine system and hematopoietic system;
  • (4) Women who are planning to give birth, pregnancy or lactation in the past 3 months;
  • (5) Mental patients;
  • (6) People with allergies, or those who are known to be allergic to this medicine and its ingredients;
  • (7) Those who have participated in other clinical trials within the past 3 months.
  • (8) The investigator judges that the survival period does not exceed 3 months;
  • (9) The investigator judged that he could not complete the study or could not comply with the requirements of the study.

研究者

发起方
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

相似试验